Carter Laura
- SEC CIK
- 0001858178
No open-market purchases or sales filed in the past year.
Current role at each company
- GOSS Gossamer Bio, Inc.Chief Scientific Officeras of Mar 22, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Carter Laura as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2023 (view filing) | Mar 16 | 4 days | Carter LauraChief Scientific Officer | SSale | −6.03K | $1.10 | −$6.63K | −7.3%76.3K after | |
| Oct 27, 2022 (view filing) | Oct 24 | 3 days | Carter LauraChief Scientific Officer | SSale | −4.88K | $12.07 | −$58.9K | −5.6%82.3K after | Amended |
| Jul 15, 2022 (view filing) | Jul 15 | Same day | Carter LauraChief Scientific Officer | PPurchase | +6.93K | $7.21 | +$50.0K | +8.6%87.2K after | |
| Jul 5, 2022 (view filing) | Jul 1 | 4 days | Carter LauraChief Scientific Officer | SSale | −8.81K | $8.25 | −$72.7K | −9.9%80.2K after | |
| May 5, 2022 (view filing) | May 4 | 1 day | Carter LauraChief Scientific Officer | SSale | −1.26K | $7.20 | −$9.09K | −1.4%89.0K after | |
| Mar 17, 2022 (view filing) | Mar 16 | 1 day | Carter LauraChief Scientific Officer | SSale | −5.00K | $8.28 | −$41.4K | −5.2%90.3K after | |
| Oct 26, 2021 (view filing) | Oct 25 | 1 day | Carter LauraChief Scientific Officer | SSale | −2.38K | $12.25 | −$29.1K | −2.4%95.3K after |